VITAL: Vaccines and Infectious Diseases in the Ageing Population

The VITAL project was launched in 2019, aiming to improve the efficacy of vaccines to protect the growing aging population against infectious diseases, by providing evidence-based knowledge on vaccination strategies to establish healthy aging. The project assesses infectious disease burden and mechanisms of immunosenescence by establishing links with existing projects combined with novel data acquired through an extensive network of data registries across Europe. Different partners share their expertise across different Work Packages. P95 leads Work Package 1, which aims to quantify the direct burden of infectious diseases in an aging population (50 years +) across European countries. 

The VITAL project is funded by the Innovative Medicines Initiative 2 with support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations.

Read more about VITAL on the project website: https://vital-imi.eu/